AnnouncementsAbbott India: Change in directorate
|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||0.00||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||674,631|
|Reliance Pharma Fund (G)||370,641|
|Reliance Long Term Equity Fund (G)||204,526|
|Reliance Tax Saver (ELSS) Fund (G)||71,288|
Abbott India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 3,511.77 crore.The company has reported a standalone sales of Rs 471.81 crore and a Net Profit of Rs 53.46 crore for the quarter ended Dec 2013.
The company management includes Munir Shaikh - Chairman, Rehan A Khan - Managing Director, Kaiyomarz Marfatia - Whole Time Director, Rajendra Shah - Independent Director, Ashok Dayal - Independent Director, Ranjan Kapur - Independent Director, Bhaskar lyer - Additional Director, Sachin Dharap - Additional Director, Valentine Yien - Additional Director.
It is listed on the BSE with a BSE Code of 500488 and the NSE with an NSE Code of ABBOTINDIA.
Its Registered office is at 3/4, Corporate Park, Sion Trombay Road,,Chembur Mumbai,Maharashtra - 400071.
Their Registrars are Sharepro Services (India) Pvt.Ltd.